Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.8%

2 terminated/withdrawn out of 17 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

7(46.7%)

Phase 4

5(33.3%)

Phase 3

2(13.3%)

Phase 2

1(6.7%)

15Total

N/A(7)

Phase 4(5)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT07115056Phase 4Withdrawn

Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction

Role: lead

NCT07024654Phase 2Withdrawn

Genicular Embolization Using Doxycycline Sclerotherapy

Role: lead

NCT05789784Not ApplicableEnrolling By Invitation

Study of Zimmer Biomet Mymobility Application on Reverse Total Shoulder Arthroplasty (RTSA) Outcomes

Role: lead

NCT04575688Phase 4Enrolling By Invitation

Periarticular Injection Versus Popliteal Block

Role: lead

NCT05215236Not ApplicableCompleted

Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair

Role: lead

NCT06848023Enrolling By Invitation

Reverse Shoulder Arthroplasty vs Rotator Cuff Repair for 60+

Role: lead

NCT03704766Not ApplicableRecruiting

Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Role: collaborator

NCT04250415Active Not Recruiting

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

Role: collaborator

NCT06618820Phase 3Enrolling By Invitation

Extended Oral Tranexamic Acid After Total Knee Arthroplasty

Role: lead

NCT06619340Phase 4Enrolling By Invitation

EXPAREL IPSA Block in Knee Arthroplasty

Role: lead

NCT06561035Phase 3Enrolling By Invitation

ACL-R Opioid Sparing Study

Role: lead

NCT05099276Phase 4Active Not Recruiting

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

Role: lead

NCT05438277Phase 4Completed

Pain Increases After Shoulder Injection

Role: lead

NCT04294680Not ApplicableCompleted

Opiate Sparing Versus Opiate Based Following Shoulder Arthroplasty

Role: lead

NCT05414942Not ApplicableCompleted

Opioid Reduction Program for Total Knee Replacement Patients

Role: collaborator

NCT04225468Not ApplicableCompleted

Safe Options for ACL Recovery

Role: collaborator

NCT01101607Not ApplicableCompleted

Closed Reduction of Distal Forearm Fractures by Pediatric Emergency Medicine Physicians: A Prospective Study

Role: collaborator

All 17 trials loaded